CCME Global Ltd (GENESIS) — shareholding pattern, promoter holding, financials and share price
About CCME Global Ltd (GENESIS)
CCME Global Ltd operates in the Biotechnology industry, within the Healthcare sector. It trades on the NSE as GENESIS and on the BSE under scrip code 514336. Its ISIN is INE194N01016.
Incorporated in 1992, Genesis IBRC India Ltd (Formerly SSK Lifestyles Limited) is in the business of Biotechnology.
Genesis IBRC India Ltd, originally Fine Plast Polymers Ltd, primarily manufactures rigid PVC pipes and fittings, catering largely to agriculture and industry applications.
Throughout its history, Genesis IBRC India Ltd has experienced multiple name changes and strategic shifts, including a venture into lifestyle products and probiotic manufacturing.
Listed peers in Biotechnology: Zim Laboratories Ltd, Haleos Labs Limited, Jenburkt Pharmaceuticals Ltd, Bafna Pharmaceuticals Ltd, Transchem Ltd, Albert David Ltd.
Valuation & Returns
At ₹110 a share, CCME Global Ltd (GENESIS) was valued at a price-to-earnings ratio of -732.61x against an industry P/E of 36.41x and a price-to-book of 12.98x on a book value of ₹8.86 per share. Solomo computes return on equity of -1.78% and return on capital employed of -1.78% from filed results.
- P/E
- -732.61x
- Industry P/E
- 36.41x
- P/B
- 12.98x
- EPS (TTM)
- ₹-0.03
- Book value / share
- ₹8.86
- ROE
- -1.78%
- ROCE
- -1.78%
- ROA
- -1.57%
- Debt / equity
- 0x
- Dividend yield
- 0%
- 52-week range
- ₹23.39 – ₹184.9
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2018In the year ended Mar 2018, CCME Global Ltd (GENESIS) reported revenue of ₹4.33 crore, net profit of ₹-0.03 crore and earnings per share of ₹-0.02. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹0.04 crore and net profit ₹-0.5 crore (standalone).
| Metric | Mar 2018 |
|---|---|
| Revenue (₹ cr) | 4.33 |
| Net profit (₹ cr) | -0.03 |
| EPS (₹) | -0.02 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Profit growth | 29.32% | - | - | 192.11% |
| Stock price CAGR | 21% | 71% | 114% | 372% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 74.35% of CCME Global Ltd (GENESIS) (up 0.18 pp QoQ). Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: VIDHUMOHAN PILLAI 4.42%, NOOR MUHAMMED HABIBULLAH 4.42%, SURESH KUMAR RAMANI 4.42%, LLP 2.43%, JAYA BHARATHI RAPARLA 1.81%, NAGA KANAKA DURGA PRASAD CHALAVADI 1.77%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 74.35% | - | - | - | 25.65% |
| Mar 2026 | 74.17% | - | - | - | 25.83% |
| Dec 2025 | 11.33% | - | - | - | 88.67% |
| Sep 2025 | 11.33% | - | - | - | 88.67% |
| Jun 2025 | 11.33% | - | - | - | 88.67% |
| Mar 2025 | 11.33% | - | - | - | 88.67% |
| Dec 2024 | 11.33% | - | - | - | 88.67% |
| Sep 2024 | 11.33% | - | - | - | 88.67% |